Elevated pulmonary vascular resistance (PVR), a measure of how difficult it is for blood to move from the heart to the lungs, was associated with a higher risk of poor outcomes in people with pulmonary hypertension (PH) due to left heart disease, a real-world study in Japan shows. The…
Data from smartphones and wearable devices may help with the early detection of idiopathic pulmonary arterial hypertension (IPAH), a rare lung disease with no known cause, a study suggests. Using up to eight years of data obtained via the My Heart Counts iOS app, device-derived data helped distinguish…
Discussion
Growing up with a rare, chronic illness can draw a lot of attention. Specifically, it can raise a lot of questions, especially from other kids. I can’t remember an age when I wasn’t required to explain my health situation to others, particularly my peers. Early on, absences from school would…
Building on positive data from an earlier study, Allrock Bio has dosed the first patients in a small clinical trial testing ROC-101, its oral treatment candidate for pulmonary hypertension (PH). The open-label Phase 2a ROCSTAR study (NCT07175038) is recruiting patients across the U.S., Canada, and Europe — including…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
